Comparison of antipseudomonal β-lactams for febrile neutropenia empiric therapy: authors' response

Clin Microbiol Infect. 2018 Mar;24(3):325. doi: 10.1016/j.cmi.2017.11.013. Epub 2017 Nov 23.

Authors

N Horita¹, Y Shibata², H Watanabe², H Namkoong³, T Kaneko²

Affiliations

¹ Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan. Electronic address: horitano@yokohama-cu.ac.jp.
² Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
³ Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.

PMID: 29175350
DOI: 10.1016/j.cmi.2017.11.013

No abstract available

Publication types

Letter
Comment

MeSH terms

Aminoglycosides
Anti-Bacterial Agents
Cephalosporins*
Drug Therapy, Combination
Febrile Neutropenia
Fever
Humans
beta-Lactams*

Substances

Aminoglycosides
Anti-Bacterial Agents
Cephalosporins
beta-Lactams